Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
Jackie Leach Scully calls for a wide-ranging discussion of the scope and nature of human genetic variation and diversity.
Teresa Blankmeyer Burke argues for inclusion and communication accessibility in bioethics discussions that threaten to harm the signing Deaf community.
Charis M Thompson summarizes the recent debate on human germline gene editing and calls for a broader and more inclusive public discussion.


